Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s stock price traded up 8.9% during mid-day trading on Wednesday . The stock traded as high as $2.19 and last traded at $2.15. 2,124,510 shares changed hands during trading, an increase of 3,066% from the average session volume of 67,097 shares. The stock had previously closed at $1.9750.
Cardiol Therapeutics Stock Performance
The company has a 50-day moving average of $1.38 and a 200 day moving average of $1.26.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.
Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.
Further Reading
- Five stocks we like better than Cardiol Therapeutics
- Credo Technology Just Plunged 20%—Did the Market Overreact?
- Accelerant’s Take-Private Deal Raises a Bigger Question for Insurance Stocks
- 3 CEOs Are Buying Millions of Dollars of Their Beaten-Down Stocks
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
